Pharmaceutical Industry Articles & Reports - Page 13

Understand ChatGPT Enterprise connectors and Office 365, SharePoint, and Azure integrations. This guide explains RAG architecture, security, and governance.

Analyze token usage patterns and optimization techniques for ChatGPT and Claude. Understand LLM context windows, API costs, and prompt engineering strategies.

Analyze the role of AI in pharma and biotech. Learn how machine learning is applied to drug discovery and clinical trials through industry case studies.

Learn how Egnyte AI and the Model Context Protocol (MCP) integrate secure generative AI and RAG into enterprise content management and data governance.

A factual comparison of ChatGPT Enterprise vs Claude Enterprise. Analyze context windows, compliance controls, model capabilities, and enterprise pricing.

Read an in-depth 2026 comparison of leading AI coding assistants: Claude Code, Codex CLI, and Gemini CLI. Review their features, models, and market adoption.

Examine Amgen's phased enterprise AI rollout to 20,000 employees. Learn about the Microsoft Copilot pilot, security guardrails, and AI adoption metrics.

An educational guide detailing prompt strategies for ChatGPT and Claude in biotechnology. Covers prompt engineering techniques, model comparisons, and examples.

Review a comprehensive directory of Claude Cowork training resources. Access official documentation, community tutorials, video courses, and expert workshops.

Learn how OpenAI Codex assists biotech research by automating bioinformatics tasks. Read our analysis of its technical capabilities, use cases, and limitations.

Review regulatory requirements for assembling pharma AI validation evidence packages. Examine FDA and EMA guidelines, credibility frameworks, and GxP rules.

Review how Large Language Models (LLMs) extract adverse drug events from clinical notes. Learn about NLP model accuracy, implementation, and performance metrics

Analyze the FDA CDER 2026 guidance pipeline for artificial intelligence in drug manufacturing and digital health technologies in pharmaceutical development.

An educational analysis of the IQVIA.ai platform, detailing how NVIDIA-powered agentic AI orchestrates pharmaceutical operations and clinical trial workflows.

Explore how pharmaceutical companies use low-code platforms to build GxP-compliant MES and QMS applications while meeting strict 21 CFR Part 11 standards.

Examine the role of agentic AI in pharmaceutical commercial launches. Learn how autonomous multi-agent systems optimize market access and HCP engagement.

Explore how to structure a Pharma AI Center of Excellence. This guide covers organizational design, hub-and-spoke models, AI governance, and enterprise scaling.

Learn how AI-powered pharma smart factories enable autonomous GMP manufacturing, real-time quality control, and continuous production using digital twins.

Explore SAP S/4HANA implementation in pharmaceutical manufacturing. This guide details GxP compliance, module selection, and computer system validation.

Examine 2026 AI infrastructure investments in pharmaceutical R&D. This report details the Lilly-NVIDIA lab, Earendil funding, and GPU compute deployments.

Examine how pharma organizations deploy private LLMs using air-gapped AI architecture to maintain data sovereignty and comply with FDA and GDPR regulations.

This 2026 guide analyzes GxP compliance software, offering a detailed comparison of eQMS platforms, regulatory standards, and life science quality management.

Examine the 2026 landscape of AI biologics discovery. This analysis details protein modeling, generative design, and key pharma R&D investment trends.

Analyze AI robotics applications in pharma GMP manufacturing. This report details automation use cases across R&D, aseptic fill-finish, packaging, and ROI data.